Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 418

1.

The Mark Coventry Award: Prevention of readmission for venous thromboembolism after total knee arthroplasty.

Pellegrini VD Jr, Donaldson CT, Farber DC, Lehman EB, Evarts CM.

Clin Orthop Relat Res. 2006 Nov;452:21-7.

PMID:
16906107
2.

The John Charnley Award: prevention of readmission for venous thromboembolic disease after total hip arthroplasty.

Pellegrini VD Jr, Donaldson CT, Farber DC, Lehman EB, Evarts CM.

Clin Orthop Relat Res. 2005 Dec;441:56-62.

PMID:
16330984
3.
4.
5.

The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.

Chotanaphuti T, Ongnamthip P, Silpipat S, Foojareonyos T, Roschan S, Reumthantong A.

J Med Assoc Thai. 2007 Jul;90(7):1342-7.

PMID:
17710975
6.
7.

DVT prophylaxis: better living through chemistry: affirms.

Pellegrini VD.

Orthopedics. 2010 Sep 7;33(9):642. doi: 10.3928/01477447-20100722-43.

PMID:
20839678
8.

Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment.

Pellegrini VD Jr, Sharrock NE, Paiement GD, Morris R, Warwick DJ.

Instr Course Lect. 2008;57:637-61. Review.

PMID:
18399613
9.
10.

Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).

Haas S, Breyer HG, Bacher HP, Fareed J, Misselwitz F, Victor N, Weber J; ECHOS Trial Group.

Int Angiol. 2006 Dec;25(4):335-42.

PMID:
17164738
11.

Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: a randomized, double-blind clinical trial.

Navarro-Quilis A, Castellet E, Rocha E, Paz-Jiménez J, Planès A; Bemiparin Study Group in Knee Arthroplasty.

J Thromb Haemost. 2003 Mar;1(3):425-32.

12.

A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement.

Agnelli G, Haas S, Ginsberg JS, Krueger KA, Dmitrienko A, Brandt JT.

J Thromb Haemost. 2007 Apr;5(4):746-53.

13.

Venous thromboembolism associated with hip and knee replacement over a ten-year period: a population-based study.

Howie C, Hughes H, Watts AC.

J Bone Joint Surg Br. 2005 Dec;87(12):1675-80.

PMID:
16326885
14.

[Prevention of venous thromboembolism in orthopaedics].

Kessler P.

Vnitr Lek. 2006 Mar;52 Suppl 1:51-7. Review. Czech.

PMID:
16637450
16.

BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study.

Turpie AG, Fisher WD, Bauer KA, Kwong LM, Irwin MW, Kälebo P, Misselwitz F, Gent M; OdiXa-Knee Study Group.

J Thromb Haemost. 2005 Nov;3(11):2479-86.

17.

Deep venous thrombosis after total hip or total knee arthroplasty in patients in Japan.

Fujita S, Hirota S, Oda T, Kato Y, Tsukamoto Y, Fuji T.

Clin Orthop Relat Res. 2000 Jun;(375):168-74.

PMID:
10853166
18.

Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty.

Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL.

Anesthesiology. 2003 Sep;99(3):552-60; discussion 5A.

PMID:
12960538
19.

Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement: results from Phase II studies.

Eriksson BI, Ogren M, Eriksson UG, Kälebo P, Ahnfelt L, Björkström S, Sjöstedt A, Folestad A, Arfwidsson AC, Elvander CS, Frison L.

Thromb Res. 2002 Mar 1;105(5):371-8.

PMID:
12062537
20.

Venous thromboembolism following total knee replacement.

Choi BY, Huo MH.

J Surg Orthop Adv. 2007 Spring;16(1):31-5. Review.

PMID:
17371645

Supplemental Content

Support Center